BiotechTube
Home/Xenetic Biosciences/James F. Parslow
JF

James F. Parslow

Interim Chief Executive Officer and Chief Financial Officer

Xenetic Biosciences

Therapeutic Areas

OncologyImmuno-Oncology

Xenetic Biosciences Pipeline

DrugIndicationPhase
Systemic DNase IPancreatic CarcinomaPre-clinical
DNase-Armored CAR T PlatformMultiple Solid CancersResearch

Leadership Team at Xenetic Biosciences

SN
Scott N. Cullison
Executive Consultant for Business Development
RP
Reid P. Bissonnette, Ph.D.
Executive Consultant for Translational Research and Development
GG
Grigory G. Borisenko, Ph.D.
Non-Executive Director
FJ
Firdaus Jal Dastoor, FCS
Non-Executive Director
DG
Dmitry Genkin, MD
Non-Executive Director
RK
Roger Kornberg, Ph.D.
Non-Executive Director
JS
Jonathan Spicer, M.D., Ph.D.
Scientific Advisory Board Member
AT
Allan Tsung, M.D.
Scientific Advisory Board Member
MF
Matthew Frigault, M.D.
Scientific Advisory Board Member
View full Xenetic Biosciences profile